RLAY
Price
$2.29
Change
-$0.20 (-8.03%)
Updated
Apr 3 closing price
Capitalization
389.05M
27 days until earnings call
RZLT
Price
$2.74
Change
-$0.28 (-9.27%)
Updated
Apr 3 closing price
Capitalization
165.56M
46 days until earnings call
Ad is loading...

RLAY vs RZLT

Header iconRLAY vs RZLT Comparison
Open Charts RLAY vs RZLTBanner chart's image
Relay Therapeutics
Price$2.29
Change-$0.20 (-8.03%)
Volume$2.79M
Capitalization389.05M
Rezolute
Price$2.74
Change-$0.28 (-9.27%)
Volume$775.71K
Capitalization165.56M
RLAY vs RZLT Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. RZLT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and RZLT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (RLAY: $2.29 vs. RZLT: $2.73)
Brand notoriety: RLAY and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 134% vs. RZLT: 139%
Market capitalization -- RLAY: $389.05M vs. RZLT: $165.56M
RLAY [@Biotechnology] is valued at $389.05M. RZLT’s [@Biotechnology] market capitalization is $165.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 1 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both RLAY and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 5 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • RZLT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than RLAY.

Price Growth

RLAY (@Biotechnology) experienced а -23.41% price change this week, while RZLT (@Biotechnology) price change was -6.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

RLAY is expected to report earnings on May 01, 2025.

RZLT is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($389M) has a higher market cap than RZLT($166M). RZLT (-44.082) and RLAY (-44.417) have similar YTD gains . RZLT has higher annual earnings (EBITDA): -73.3M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. RZLT (96.5M). RZLT has less debt than RLAY: RZLT (1.93M) vs RLAY (48.5M). RLAY has higher revenues than RZLT: RLAY (10M) vs RZLT (0).
RLAYRZLTRLAY / RZLT
Capitalization389M166M234%
EBITDA-380.21M-73.3M519%
Gain YTD-44.417-44.082101%
P/E RatioN/AN/A-
Revenue10M0-
Total Cash781M96.5M809%
Total Debt48.5M1.93M2,510%
FUNDAMENTALS RATINGS
RZLT: Fundamental Ratings
RZLT
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYRZLT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRUAX23.84N/A
N/A
Franklin Utilities Adv
TEMRX8.09N/A
N/A
Nuveen Emerging Markets Eq A
AWSRX15.31N/A
N/A
Invesco Global Core Equity R
HSEIX11.83N/A
N/A
Hartford Small Cap Value I
SRIAX12.78N/A
N/A
Gabelli SRI A

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-8.03%
XNCR - RLAY
47%
Loosely correlated
-9.16%
VCYT - RLAY
44%
Loosely correlated
-5.51%
BCYC - RLAY
44%
Loosely correlated
-7.70%
FHTX - RLAY
44%
Loosely correlated
-7.89%
BDTX - RLAY
43%
Loosely correlated
-4.43%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-9.27%
RLAY - RZLT
36%
Loosely correlated
-8.03%
ABEO - RZLT
31%
Poorly correlated
+5.77%
RYTM - RZLT
30%
Poorly correlated
-4.12%
ANNX - RZLT
30%
Poorly correlated
-6.63%
IMNM - RZLT
29%
Poorly correlated
-7.00%
More